Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?

Stroke is a leading cause of death and disability and is responsible for a significant economic burden. Sarcopenia and cognitive dysfunction are common consequences of stroke, but there is less awareness of the concurrency of these conditions. In addition, few reviews are available to guide clinicia...

Full description

Bibliographic Details
Main Authors: Sophia X. Sui, Brenton Hordacre, Julie A. Pasco
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/2/223
id doaj-cf555f015bcd4171bc8bab47694e7446
record_format Article
spelling doaj-cf555f015bcd4171bc8bab47694e74462021-02-23T00:01:05ZengMDPI AGBiomedicines2227-90592021-02-01922322310.3390/biomedicines9020223Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?Sophia X. Sui0Brenton Hordacre1Julie A. Pasco2IMPACT—The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, VIC 3220, AustraliaIIMPACT in Health, Allied Health and Human Performance, University of South Australia, Adelaide, SA 5000, AustraliaIMPACT—The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, VIC 3220, AustraliaStroke is a leading cause of death and disability and is responsible for a significant economic burden. Sarcopenia and cognitive dysfunction are common consequences of stroke, but there is less awareness of the concurrency of these conditions. In addition, few reviews are available to guide clinicians and researchers on how to approach sarcopenia and cognitive dysfunction as comorbidities after stroke, including how to assess and manage them and implement interventions to improve health outcomes. This review synthesises current knowledge about the relationship between post-stroke sarcopenia and cognitive dysfunction, including the physiological pathways, assessment tools, and interventions involved.https://www.mdpi.com/2227-9059/9/2/223strokepost strokesarcopeniacognitive dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author Sophia X. Sui
Brenton Hordacre
Julie A. Pasco
spellingShingle Sophia X. Sui
Brenton Hordacre
Julie A. Pasco
Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
Biomedicines
stroke
post stroke
sarcopenia
cognitive dysfunction
author_facet Sophia X. Sui
Brenton Hordacre
Julie A. Pasco
author_sort Sophia X. Sui
title Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
title_short Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
title_full Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
title_fullStr Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
title_full_unstemmed Are Sarcopenia and Cognitive Dysfunction Comorbid after Stroke in the Context of Brain–Muscle Crosstalk?
title_sort are sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk?
publisher MDPI AG
series Biomedicines
issn 2227-9059
publishDate 2021-02-01
description Stroke is a leading cause of death and disability and is responsible for a significant economic burden. Sarcopenia and cognitive dysfunction are common consequences of stroke, but there is less awareness of the concurrency of these conditions. In addition, few reviews are available to guide clinicians and researchers on how to approach sarcopenia and cognitive dysfunction as comorbidities after stroke, including how to assess and manage them and implement interventions to improve health outcomes. This review synthesises current knowledge about the relationship between post-stroke sarcopenia and cognitive dysfunction, including the physiological pathways, assessment tools, and interventions involved.
topic stroke
post stroke
sarcopenia
cognitive dysfunction
url https://www.mdpi.com/2227-9059/9/2/223
work_keys_str_mv AT sophiaxsui aresarcopeniaandcognitivedysfunctioncomorbidafterstrokeinthecontextofbrainmusclecrosstalk
AT brentonhordacre aresarcopeniaandcognitivedysfunctioncomorbidafterstrokeinthecontextofbrainmusclecrosstalk
AT julieapasco aresarcopeniaandcognitivedysfunctioncomorbidafterstrokeinthecontextofbrainmusclecrosstalk
_version_ 1724255549260824576